WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareDiagnostics & Research
Best Diagnostic & Research Stocks to Buy Now (2024)
Top diagnostic & research stocks in 2024 ranked by overall Zen Score. See the best diagnostic & research stocks to buy now, according to analyst forecasts for the diagnostics & research industry.

Industry: Diagnostics & Research
Ticker
Company
Financials Score
Market Cap
ROE
ROA
ROCE
ROIC
D/E
Current Ratio
Gross Margin
Profit Margin
Operating Margin
FONR
FONAR CORP
$109.45M7.60%6.10%8.95%10.30%0.289.3545.70%11.90%16.44%
ICLR
ICON PLC
$25.55B7.50%4.00%7.31%20.70%0.811.2129.60%8.30%12.52%
STRR
STAR EQUITY HOLDINGS INC
$14.26M42.40%31.80%35.27%72.30%0.163.9926.00%50.70%51.43%
RVTY
REVVITY INC
$12.43B8.80%5.00%6.72%14.30%0.722.0756.00%25.20%29.60%
CRL
CHARLES RIVER LABORATORIES INTERNATIONAL INC
$11.99B14.30%6.10%9.98%12.30%1.261.5336.40%11.50%17.25%
NEOG
NEOGEN CORP
$2.60B0.00%0.00%1.64%5.10%0.463.8251.00%0.20%7.80%
IDXX
IDEXX LABORATORIES INC
$39.69B63.70%27.60%46.96%45.20%1.141.5760.10%23.30%30.21%
TMO
THERMO FISHER SCIENTIFIC INC
$218.49B13.30%6.20%9.61%15.50%1.131.7040.40%14.20%18.81%
A
AGILENT TECHNOLOGIES INC
$40.87B21.20%11.50%15.26%24.30%0.772.6850.60%18.40%21.14%
ENZ
ENZO BIOCHEM INC
$53.27M53.70%32.60%43.30%151.90%0.403.20112.30%254.30%249.49%
QGEN
QIAGEN NV
$9.62B9.20%5.60%9.88%15.00%0.611.8462.80%17.40%24.37%
DGX
QUEST DIAGNOSTICS INC
$15.26B13.30%6.20%10.77%16.40%1.160.9732.90%9.10%13.51%
SHC
SOTERA HEALTH CO
$3.12B13.10%1.80%9.20%7.80%6.133.2055.00%5.10%24.83%
DHR
DANAHER CORP
$183.97B8.30%5.20%7.07%19.20%0.561.8558.40%19.50%23.73%
MEDP
MEDPACE HOLDINGS INC
$12.16B59.70%19.70%42.66%-710.00%1.670.7828.00%15.90%18.24%
LH
LABORATORY CORP OF AMERICA HOLDINGS
$16.97B5.30%2.60%6.53%8.50%1.080.8827.70%3.50%6.69%
FLGT
FULGENT GENETICS INC
$643.37M-13.90%-12.80%-13.86%-17.20%0.095.0937.50%-57.70%-55.62%
WAT
WATERS CORP
$19.02B75.00%15.10%21.76%22.10%3.022.2259.60%21.70%28.25%
MTD
METTLER TOLEDO INTERNATIONAL INC
$26.89B-852.80%23.50%48.34%31.20%-23.381.0459.20%20.80%27.75%
SERA
SERA PROGNOSTICS INC
$351.82M-45.70%-37.40%-50.97%-56.70%0.362.5131.40%-11,843.80%-11,825.82%
CSTL
CASTLE BIOSCIENCES INC
$671.68M-7.90%-6.90%-7.18%-14.40%0.149.2680.60%-12.30%-12.22%
PRE
PRENETICS GLOBAL LTD
$63.83M-28.70%-22.80%-29.34%-80.70%0.212.3740.60%-288.50%-289.72%
IQV
IQVIA HOLDINGS INC
$40.70B22.60%5.20%10.60%16.30%3.190.8835.00%9.00%14.15%
PSNL
PERSONALIS INC
$77.78M-66.60%-44.50%-60.78%-64.10%0.743.1124.80%-147.40%-147.12%
NTRA
NATERA INC
$11.71B-62.20%-31.90%-37.19%-43.00%0.884.1045.50%-40.20%-38.97%
PRPO
PRECIPIO INC
$8.30M-42.10%-30.80%-39.00%-958.50%0.251.1739.60%-38.50%-38.40%
OLK
OLINK HOLDING AB (PUBL)
$2.86B-6.50%-5.60%-7.14%-27.00%0.204.7567.50%-18.60%-23.02%
DRIO
DARIOHEALTH CORP
$46.22M-91.80%-59.30%-70.76%-181.70%0.663.7929.40%-312.10%-291.68%
ACRS
ACLARIS THERAPEUTICS INC
$96.46M-52.80%-40.20%-53.38%-58.50%0.264.1642.10%-283.10%-284.32%
STIM
NEURONETICS INC
$113.37M-72.80%-29.30%-25.79%-29.70%2.394.7372.50%-42.30%-34.71%
TWST
TWIST BIOSCIENCE CORP
$2.40B-31.60%-25.40%-30.10%-52.80%0.265.5138.30%-69.20%-68.93%
NEO
NEOGENOMICS INC
$1.95B-8.90%-5.00%-5.18%-8.30%0.787.4841.80%-13.80%-13.26%
DMTK
DERMTECH INC
$21.78M-124.00%-67.90%-93.00%-69.90%1.134.591.80%-659.60%-659.57%
EXAS
EXACT SCIENCES CORP
$11.27B-6.60%-3.20%-3.06%-5.00%1.062.3273.80%-8.20%-7.29%
OCX
ONCOCYTE CORP
$22.01M-82.30%-35.20%-40.96%-523.20%2.411.4927.50%-1,911.00%-1,844.91%
RDNT
RADNET INC
$3.51B0.60%0.10%3.37%2.80%2.981.3213.70%0.20%4.70%
BNR
BURNING ROCK BIOTECH LTD
$82.67M-71.70%-52.80%-83.86%-261.80%0.353.3667.60%-121.60%-121.19%
BGLC
BIONEXUS GENE LAB CORP
$10.67M-33.00%-27.00%-26.55%-42.20%0.184.9313.60%-26.90%-26.54%
APDN
APPLIED DNA SCIENCES INC
$3.18M-110.20%-49.80%-98.41%-310.50%1.371.7737.60%-81.00%-80.13%
LAB
STANDARD BIOTOOLS INC
$728.20MN/A-21.50%-32.58%-39.50%-1.081.4547.40%-70.20%-65.49%
GH
GUARDANT HEALTH INC
$2.30B-301.90%-27.70%-30.13%-20.50%10.266.5459.70%-85.00%-84.44%
XWEL
XWELL INC
$7.49M-115.00%-54.70%-93.40%-68.20%1.392.8512.20%-92.10%-92.02%
XGN
EXAGEN INC
$24.13M-80.30%-36.30%-47.34%-47.60%1.514.0256.10%-45.10%-40.57%
BDSX
BIODESIX INC
$135.72M-30,185.80%-60.60%-64.88%-71.00%20.641.1973.50%-106.20%-86.81%
CDNA
CAREDX INC
$503.29M-51.40%-37.80%-51.96%-69.10%0.794.0263.60%-67.90%-72.06%
ME
23ANDME HOLDING CO
$242.42M-87.30%-64.80%-112.60%-534.30%0.612.1545.30%-210.50%-210.72%
CHEK
CHECK-CAP LTD
$12.87M-51.90%-47.10%-70.88%-69.30%0.0617.60N/AN/AN/A
ULS
UL SOLUTIONS INC
N/AN/AN/A18.01%N/A3.151.3447.80%9.70%13.63%
PRPH
PROPHASE LABS INC
$97.81M-29.80%-18.10%-30.29%-30.70%0.862.2836.60%-37.80%-48.50%
AWH
ASPIRA WOMEN's HEALTH INC
$39.62MN/A-195.50%-1,460.19%-2,159.10%-3.651.0357.50%-182.30%-182.32%
NDRA
ENDRA LIFE SCIENCES INC
$3.61M-180.60%-133.00%-171.94%-341.40%0.193.36N/AN/AN/A
OPK
OPKO HEALTH INC
$906.09M-12.80%-9.00%-9.43%-24.70%0.451.5536.80%-21.90%-19.79%
NOTV
INOTIV INC
$110.13M-12.40%-3.90%0.53%0.50%2.291.7430.30%-5.70%0.66%
VNRX
VOLITIONRX LTD
$73.12MN/A-154.20%903.04%391.60%-4.700.69100.00%-4,555.50%-4,526.94%
MDXH
MDXHEALTH SA
$8.57M-314.60%-30.20%-27.74%-27.20%-126.121.6962.80%-53.00%-37.86%
GENE
GENETIC TECHNOLOGIES LTD
$520.53k-160.90%-105.50%-252.20%-5,353.20%0.761.6753.50%-150.00%-149.85%
MYGN
MYRIAD GENETICS INC
$1.75B-34.70%-22.60%-26.18%-61.20%0.462.0168.60%-35.00%-34.43%
ISPC
ISPECIMEN INC
$2.39M-80.40%-62.00%-113.44%-227.60%0.621.3651.40%-111.80%-111.64%
BIAF
BIOAFFINITY TECHNOLOGIES INC
$24.07M-107.20%-84.10%-131.89%-540.30%0.691.7731.30%-313.40%-311.11%
ILMN
ILLUMINA INC
$18.79B-21.50%-12.30%-12.53%-25.10%0.751.7561.40%-28.70%-23.88%
PMD
PSYCHEMEDICS CORP
$14.64M-49.80%-27.40%-45.14%-34.10%0.851.4538.10%-18.80%-15.56%
TRIB
TRINITY BIOTECH PLC
$13.81MN/A-33.60%-29.33%-13.10%-3.482.6034.20%-42.30%-22.92%
MYNZ
MAINZ BIOMED NV
$15.60M-488.00%-145.80%-412.93%-1,525.40%3.740.9756.90%-2,936.50%-2,846.09%
MMA
ALTA GLOBAL GROUP LTD
N/AN/AN/A77.57%N/A-0.550.2285.00%-1,340.30%-1,049.23%
CNTG
CENTOGENE NV
$12.22M-1,921.20%-69.80%-113.83%-68.10%-5.721.4540.00%-111.50%-100.99%
TTOO
T2 BIOSYSTEMS INC
$20.51MN/A-135.40%209.48%-175.70%-2.240.45-113.60%-696.20%-621.91%

Diagnostic & Research Stocks FAQ

What are the best diagnostic & research stocks to buy right now in May 2024?

According to Zen Score, the 3 best diagnostic & research stocks to buy right now are:

1. Fonar (NASDAQ:FONR)


Fonar (NASDAQ:FONR) is the top diagnostic & research stock with a Zen Score of 47, which is 20 points higher than the diagnostic & research industry average of 27. It passed 14 out of 33 due diligence checks and has strong fundamentals. Fonar has seen its stock return 3.69% over the past year, overperforming other diagnostic & research stocks by 4 percentage points.

2. Icon (NASDAQ:ICLR)


Icon (NASDAQ:ICLR) is the second best diagnostic & research stock with a Zen Score of 47, which is 20 points higher than the diagnostic & research industry average of 27. It passed 15 out of 33 due diligence checks and has strong fundamentals. Icon has seen its stock return 66.35% over the past year, overperforming other diagnostic & research stocks by 67 percentage points.

Icon has an average 1 year price target of $344.38, an upside of 11.44% from Icon's current stock price of $309.02.

Icon stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 8 analysts covering Icon, 75% have issued a Strong Buy rating, 25% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Star Equity Holdings (NASDAQ:STRR)


Star Equity Holdings (NASDAQ:STRR) is the third best diagnostic & research stock with a Zen Score of 46, which is 19 points higher than the diagnostic & research industry average of 27. It passed 18 out of 38 due diligence checks and has strong fundamentals. Star Equity Holdings has seen its stock return 37.4% over the past year, overperforming other diagnostic & research stocks by 38 percentage points.

What are the diagnostic & research stocks with highest dividends?

Out of 7 diagnostic & research stocks that have issued dividends in the past year, the 3 diagnostic & research stocks with the highest dividend yields are:

1. Qiagen Nv (NYSE:QGEN)


Qiagen Nv (NYSE:QGEN) has an annual dividend yield of 2.98%, which is 2 percentage points higher than the diagnostic & research industry average of 1.36%.

Qiagen Nv's dividend payout ratio of 87.2% indicates that its dividend yield is sustainable for the long-term.

2. Quest Diagnostics (NYSE:DGX)


Quest Diagnostics (NYSE:DGX) has an annual dividend yield of 2.1%, which is 1 percentage points higher than the diagnostic & research industry average of 1.36%. Quest Diagnostics's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Quest Diagnostics's dividend has shown consistent growth over the last 10 years.

Quest Diagnostics's dividend payout ratio of 38.2% indicates that its dividend yield is sustainable for the long-term.

3. Laboratory Of America Holdings (NYSE:LH)


Laboratory Of America Holdings (NYSE:LH) has an annual dividend yield of 1.43%, which is the same as the diagnostic & research industry average of 1.36%. Laboratory Of America Holdings's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Laboratory Of America Holdings's dividend has not shown consistent growth over the last 10 years.

Laboratory Of America Holdings's dividend payout ratio of 56.5% indicates that its dividend yield is sustainable for the long-term.

Why are diagnostic & research stocks up?

Diagnostic & research stocks were up 0.85% in the last day, and up 0.7% over the last week. Twist Bioscience was the among the top gainers in the diagnostics & research industry, gaining 28.74% yesterday.

Twist Bioscience shares are trading higher after the company reported better-than-expected Q2 financial results.

What are the most undervalued diagnostic & research stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued diagnostic & research stocks right now are:

1. Star Equity Holdings (NASDAQ:STRR)


Star Equity Holdings (NASDAQ:STRR) is the most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Star Equity Holdings has a valuation score of 71, which is 52 points higher than the diagnostic & research industry average of 19. It passed 5 out of 7 valuation due diligence checks.

Star Equity Holdings's stock has gained 37.4% in the past year. It has overperformed other stocks in the diagnostic & research industry by 38 percentage points.

2. Enzo Biochem (NYSE:ENZ)


Enzo Biochem (NYSE:ENZ) is the second most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Enzo Biochem has a valuation score of 71, which is 52 points higher than the diagnostic & research industry average of 19. It passed 5 out of 7 valuation due diligence checks.

Enzo Biochem's stock has dropped -59.85% in the past year. It has underperformed other stocks in the diagnostic & research industry by -59 percentage points.

3. Fonar (NASDAQ:FONR)


Fonar (NASDAQ:FONR) is the third most undervalued diagnostic & research stock based on WallStreetZen's Valuation Score. Fonar has a valuation score of 71, which is 52 points higher than the diagnostic & research industry average of 19. It passed 5 out of 7 valuation due diligence checks.

Fonar's stock has gained 3.69% in the past year. It has overperformed other stocks in the diagnostic & research industry by 4 percentage points.

Are diagnostic & research stocks a good buy now?

52.08% of diagnostic & research stocks rated by analysts are a strong buy right now. On average, analysts expect diagnostic & research stocks to rise by 10.51% over the next year.

What is the average p/e ratio of the diagnostics & research industry?

The average P/E ratio of the diagnostics & research industry is 38.44x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.